These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19956686)

  • 1. Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor.
    Dallosso AR; Hancock AL; Szemes M; Moorwood K; Chilukamarri L; Tsai HH; Sarkar A; Barasch J; Vuononvirta R; Jones C; Pritchard-Jones K; Royer-Pokora B; Lee SB; Owen C; Malik S; Feng Y; Frank M; Ward A; Brown KW; Malik K
    PLoS Genet; 2009 Nov; 5(11):e1000745. PubMed ID: 19956686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways.
    Dallosso AR; Øster B; Greenhough A; Thorsen K; Curry TJ; Owen C; Hancock AL; Szemes M; Paraskeva C; Frank M; Andersen CL; Malik K
    Oncogene; 2012 Oct; 31(40):4409-19. PubMed ID: 22249255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial Effects of Alpha- and Gamma-Protocadherins on Neuronal Survival and Dendritic Self-Avoidance.
    Ing-Esteves S; Kostadinov D; Marocha J; Sing AD; Joseph KS; Laboulaye MA; Sanes JR; Lefebvre JL
    J Neurosci; 2018 Mar; 38(11):2713-2729. PubMed ID: 29439167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the Wnt/β-catenin pathway is common in wilms tumor, but rarely through β-catenin mutation and APC promoter methylation.
    Schweigert A; Fischer C; Mayr D; von Schweinitz D; Kappler R; Hubertus J
    Pediatr Surg Int; 2016 Dec; 32(12):1141-1146. PubMed ID: 27679509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of epigenetic states by WT1 via regulation of de novo DNA methyltransferase 3A.
    Szemes M; Dallosso AR; Melegh Z; Curry T; Li Y; Rivers C; Uney J; Mägdefrau AS; Schwiderski K; Park JH; Brown KW; Shandilya J; Roberts SG; Malik K
    Hum Mol Genet; 2013 Jan; 22(1):74-83. PubMed ID: 23042785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustered protocadherins methylation alterations in cancer.
    Vega-Benedetti AF; Loi E; Moi L; Blois S; Fadda A; Antonelli M; Arcella A; Badiali M; Giangaspero F; Morra I; Columbano A; Restivo A; Zorcolo L; Gismondi V; Varesco L; Bellomo SE; Giordano S; Canale M; Casadei-Gardini A; Faloppi L; Puzzoni M; Scartozzi M; Ziranu P; Cabras G; Cocco P; Ennas MG; Satta G; Zucca M; Canzio D; Zavattari P
    Clin Epigenetics; 2019 Jul; 11(1):100. PubMed ID: 31288858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
    Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
    Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.
    Wu Q; Zhang T; Cheng JF; Kim Y; Grimwood J; Schmutz J; Dickson M; Noonan JP; Zhang MQ; Myers RM; Maniatis T
    Genome Res; 2001 Mar; 11(3):389-404. PubMed ID: 11230163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells.
    Yang X; Chen MW; Terry S; Vacherot F; Chopin DK; Bemis DL; Kitajewski J; Benson MC; Guo Y; Buttyan R
    Cancer Res; 2005 Jun; 65(12):5263-71. PubMed ID: 15958572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Methylation Analysis of the PCDHB Gene Cluster.
    Banelli B; Romani M
    Methods Mol Biol; 2015; 1315():189-200. PubMed ID: 26103900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.
    Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER
    Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canonical WNT signalling determines lineage specificity in Wilms tumour.
    Fukuzawa R; Anaka MR; Weeks RJ; Morison IM; Reeve AE
    Oncogene; 2009 Feb; 28(8):1063-75. PubMed ID: 19137020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agglomerative epigenetic aberrations are a common event in human breast cancer.
    Novak P; Jensen T; Oshiro MM; Watts GS; Kim CJ; Futscher BW
    Cancer Res; 2008 Oct; 68(20):8616-25. PubMed ID: 18922938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
    Moskalev EA; Luckert K; Vorobjev IA; Mastitsky SE; Gladkikh AA; Stephan A; Schrenk M; Kaplanov KD; Kalashnikova OB; Pötz O; Joos TO; Hoheisel JD
    BMC Cancer; 2012 Jun; 12():213. PubMed ID: 22672427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of clustered protocadherin genes in individual neurons.
    Hirayama T; Yagi T
    Semin Cell Dev Biol; 2017 Sep; 69():122-130. PubMed ID: 28591566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant reduction of WT1 gene expression, possibly due to epigenetic alteration in Wilms' tumor.
    Satoh Y; Nakagawachi T; Nakadate H; Kaneko Y; Masaki Z; Mukai T; Soejima H
    J Biochem; 2003 Mar; 133(3):303-8. PubMed ID: 12761165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.
    Li CM; Kim CE; Margolin AA; Guo M; Zhu J; Mason JM; Hensle TW; Murty VV; Grundy PE; Fearon ER; D'Agati V; Licht JD; Tycko B
    Am J Pathol; 2004 Dec; 165(6):1943-53. PubMed ID: 15579438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilms tumor suppressor, WT1, suppresses epigenetic silencing of the β-catenin gene.
    Akpa MM; Iglesias DM; Chu LL; Cybulsky M; Bravi C; Goodyer PR
    J Biol Chem; 2015 Jan; 290(4):2279-88. PubMed ID: 25331950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The γ-Protocadherin-C3 isoform inhibits canonical Wnt signalling by binding to and stabilizing Axin1 at the membrane.
    Mah KM; Houston DW; Weiner JA
    Sci Rep; 2016 Aug; 6():31665. PubMed ID: 27530555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.